Biodesix Inc (BDSX) reports a 45% revenue increase in 2024, with strategic moves to expand market access and improve ...

ADMA Biologics Inc (ADMA) reports a 65% revenue surge and outlines future growth strategies amid regulatory and operational ...

Quantum-Si Inc (QSI) reports a 183% annual revenue increase and strategic milestones, despite challenges in market penetration and funding uncertainties.

ThredUp Inc (TDUP) reports a 9.5% revenue increase and AI-driven enhancements, despite a drop in active buyers and challenges in the consumer environment.

Mersana Therapeutics Inc (MRSN) reports promising clinical progress and improved financial metrics, positioning itself ...